A neurotensin agonist and antagonist decrease and increase activity, respectively, but do not preclude discrete cue conditioning

Journal of Psychopharmacology

Volumn 24, Issue 3, 2010, Pages 373-381

  Norman, C ^a,b   Grimond Billa, S K ^a   Bennett, G W ^a   Cassaday, H J ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

Author keywords

Appetitive conditioning; Neurotensin; PD149163; Rat; SR142948A; Trace conditioning

Indexed keywords

2 [5 (2,6 DIMETHOXYPHENYL) 1 [4 [N (3 DIMETHYLAMINOPROPYL) N METHYLCARBAMOYL] 2 ISOPROPYLPHENYL] 1H PYRAZOL 3 YLCARBONYLAMINO]ADAMANTANE 2 CARBOXYLIC ACID; CENTRAL NERVOUS SYSTEM AGENTS; NEUROTENSIN; NEUROTENSIN RECEPTOR; NEUROTENSIN RECEPTOR AGONIST; NEUROTENSIN RECEPTOR ANTAGONIST; PD 149163; UNCLASSIFIED DRUG; ADAMANTANE; DRUG DERIVATIVE; IMIDAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; ASSOCIATION; BRAIN ELECTROPHYSIOLOGY; BRAIN FUNCTION; CONDITIONING; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; LEARNING; MALE; NERVE STIMULATION; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RAT; ANIMAL; APPETITE; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; WISTAR RAT;

ADAMANTANE; ANIMALS; APPETITIVE BEHAVIOR; ASSOCIATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; IMIDAZOLES; MALE; NEUROTENSIN; RATS; RATS, WISTAR; RECEPTORS, NEUROTENSIN;

EID: 77953053520     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881108097721     Document Type: Article

References (40)

1. Azmi, N, Norman, C, Spicer, CH, Bennett, GW (2006) Effects of a neurotensin analogue (PD149163) and antagonist (SR142948A) on the scopolamine-induced deficits in a novel object discrimination task. Behav Pharmacol 17: 357-362. (Pubitemid 44258984)
2. Binder, EB, Gross, RE, Nemeroff, CB, Kilts, CD (2002) Effects of neurotensin receptor antagonism on latent inhibition in Sprague-Dawley rats. Psychopharmacology 161: 288-295. (Pubitemid 34591667)
3. Binder, EB, Kinkead, B, Owens, MJ, Kilts, CD, Nemeroff, CB (2001) Enhanced neurotensin neurotransmission is involved in the clinically relevant behavioral effects of antipsychotic drugs: evidence from animal models of sensorimotor gating. J Neurosci 21: 601-608. (Pubitemid 32107449)
4. Boules, M, Fredrickson, P, Richelson, E (2003) Current topics: brain penetrating neurotensin analogue. Life Sci 73: 2785-2792. (Pubitemid 37158020)
5. Cacéda, R, Kinkead, B, Nemeroff, CB (2006) Neurotensin: role in psychiatric and neurological diseases. Peptides 27: 2385-2404. (Pubitemid 44402784)
6. Cacéda, R, Kinkead, B, Owens, MJ, Nemeroff, CB (2003) Do neurotensin receptor agonists represent a novel class of antipsychotic drugs? Semin Clin Neuropsychiatry 8: 94-108.
7. Carraway, R, Leeman, SE (1973) The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami. J Biol Chem 248: 6854-6861.
8. Carraway, R, Leeman, SE (1976) Radioimmunoassay for neurotensin, a hypothalamic peptide. J Biol Chem 25: 7035-7044.
9. Cassaday, HJ, Finger, BC, Horsley, RR (2008) Methylphenidate and nicotine focus responding to an informative discrete CS over successive sessions of appetitive conditioning. J Psychopharmacol. First published on January 21, doi: 10.1177/026988110708384.
10. Cassaday, HJ, Horsley, RR, Norman, C (2005a) Electrolytic lesions to nucleus accumbens core and shell have dissociable effects on conditioning to discrete and contextual cues in aversive and appetitive procedures respectively. Behav Brain Res 160: 222-235.
11. Cassaday, HJ, Nelson, AJ, Norman, C (2005b) Haloperidol can increase responding to both discrete and contextual cues in trace conditioned rats. Behav Brain Res 158: 31-42.
12. Castner, SA, Goldman-Rakic, PS, Williams, GV (2004) Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia. Psychopharmacology (Berl) 174: 111-125.
13. Feifel, D, Minor, KL, Dulawa, S, Swerdlow, NR(1997) The effects of intra-accumbens neurotensin on sensorimotor gating. Brain Res 760: 80-84.
14. Feifel, D, Reza, TL, Wustrow, DJ, Davis, MD (1999) Novel antipsychotic-like effects on prepulse inhibition of startle produced by a neurotensin agonist. J Pharmacol Exp Ther 288: 710-713. (Pubitemid 29119685)
15. Greidanus, TVB, van Praag, MC, Kalmann, R, Rinkel, GJ, Croiset, G, Hoeke, EC, et al. (1982) Behavioral effects of neurotensin. Ann N Y Acad Sci 400: 319-329.
16. Grimond-Billa, SK, Norman, C, Bennett, GW, Cassaday, HJ (2008) Selectively increased trace conditioning under the neurotensin agonist PD 149163 in an aversive procedure in which SR 142948A was without intrinsic effect. J Psychopharmacol 22: 290-299. (Pubitemid 351847441)
17. Hawkins, MF (1996) Central nervous system neurotensin and feeding. Physiol Behav 36: 1-8.
18. Holtom, PE, Needham, PL, Bennett, GW, Aspley, S (2000) Chronic, but not acute, dosing of antipsychotic drugs alters neurotensin binding in rat brain regions. Br J Pharmacol 131: 990-996.
19. Horsley, RR, Cassaday, HJ (2007) Methylphenidate can reduce selectivity in associative learning in an aversive trace conditioning task. J Psychopharmacol 21: 492-500.
20. Kantini, E, Norman, C, Cassaday, HJ (2004) Amphetamine decreases the expression and acquisition of appetitive conditioning but increases the acquisition of anticipatory responding over a trace interval. J Psychopharmacol 18: 516-526. (Pubitemid 39665120)
21. Kaplan, PS, Hearst, E (1982) Bridging temporal gaps between CS and US in autoshaping: insertion of other stimuli before, during, and after CS. J Exp Psychol Anim Behav Process 8: 187-203.
22. Luttinger, D, King, RA, Sheppard, D, Strupp, J, Nemeroff, CB, Prange Jr, AJ (1982) The effect of Neurotensin on food consumption in the rat. Eur J Pharmacol 81: 499-503. (Pubitemid 12039791)
23. Nayak, S, Cassaday, HJ (2003) The novel dopamine D4 receptor agonist (PD 168,077 maleate): doses with different effects on locomotor activity are without effect in classical conditioning. Prog Neuropsychopharmacol Biol Psychiatry 27: 441-449. (Pubitemid 36403735)
24. Nemeroff, CB (1980) Neurotensin: perchance an endogenous neuroleptic? Biol Psychiatry 15: 283-302.
25. Nemeroff, CB (1986) The interaction of neurotensin with dopaminergic pathways in the central nervous system: basic neurobiology and implications for the pathogenesis and treatment of schizophrenia. Psychoneuroendocrinology 11: 15-37.
26. Norman, C, Beckett, SRG, Spicer, CH, Ashton, D, Langlois, X, Bennett, GW (2008) Effects of chronic infusion of neurotensin and a neurotensin NT1 selective analogue PD149163 on amphetamineinduced hyperlocomotion. J Psychopharmacol 22: 300-307. (Pubitemid 351847450)
27. Norman, C, Cassaday, HJ (2003) Amphetamine increases aversive conditioning to diffuse contextual stimuli and to a discrete trace stimulus when conditioned at higher footshock intensity. J Psychopharmacol 17: 67-76. (Pubitemid 36373142)
28. Odling-Smee, FJ (1975) Background stimuli and the interstimulus interval during Pavlovian conditioning. Q J Exp Psychol 27: 387-392.
29. Petrie, KA, Bubser, M, Casey, CD, Davis, MD, Rothe, BL, Beutch, AY (2004) The neurotensin agonist PD149163 increases fos expression in the prefrontal cortex of the rat. Neuropsychopharmacology 29: 1878-1888. (Pubitemid 39336799)
30. Prange Jr, AJ, Nemeroff, CB (1982) The manifold actions of neurotensin: a first synthesis. Ann N Y Acad Sci 400: 368-375.
31. Rawlins, JNP, Tanner, J (1998) The effects of hippocampal aspiration lesions on conditioning to the CS and to a background stimulus in trace conditioned suppression. Behav Brain Res 91: 61-72.
32. Rescorla, RA, Wagner, AR (1972) A theory of Pavlovian conditioning: variations in the effectiveness of reinforcement and nonreinforcement. In: Black, AH, Prokasy, WF (eds), Classical Conditioning II: Current Theory and Research. New York: Appleton-Century-Crofts.
33. Shilling, PD, Melendez, G, Priebe, K, Richelson, E, Feifel, D (2004) Neurotensin agonists block the prepulse inhibition deficits produced by a 5-HT2A and an alpha1 agonist. Psychopharmacology 175: 353-359. (Pubitemid 39361923)
34. Skoog,KM, Cain, ST, Nemeroff, CB (1986) Centrally administered neurotensin suppresses locomotor hyperactivity induced by d-amphetamine but not by scopolamine or caffeine. Neuropharmacology 25: 777-782.
35. Sweatt, JD (2004) Hippocampal function in cognition. Psychopharmacology (Berl) 174: 99-110.
36. Thibaudeau, G, Potvin, O, Allen, K, Dore, FY, Goulet, S (2007) Dorsal, ventral, and complete excitotoxic lesions of the hippocampus in rats failed to impair appetitive trace conditioning. Behav Brain Res 185: 9-20. (Pubitemid 47552571)
37. Vincent, JP, Mazella, J, Kitabgi, P (1999) Neurotensin and neurotensin receptors. Trends Pharmacol Sci 20: 302-309.
38. Weiner, I (1990) Neural substrates of latent inhibition: the switching model. Psychol Bull 108: 42-61.
39. Weiner, I (2003) The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment. Psychopharmacology (Berl) 169: 257-297.
40. Widerlov, E, Lindstrom, LH, Besev, G, Manberg, PJ, Nemeroff, CB, Breese, GR, et al. (1982) Subnormal CSF levels of neurotensin in a subgroup of schizophrenic patients: normalization after neuroleptic treatment. Am J Psychiatry 139: 1122-1126. (Pubitemid 12051590)